Get started
Author

Serena De Matteis

Observed names: DE MATTEIS, Serena, De Matteis, S., De Matteis, Serena, Matteis, Serena, Matteis, Serena De, S De Matteis, S. De Matteis
Observed institutions: University of Verona, University of Salento, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ematologia di Bologna, University of Bologna
ORCID: 0000-0001-9219-4081
Observed ORCID: 0000-0001-9219-4081
OpenAlex ID: A5078490973
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
2018 · Giorgia Marisi, Alessandro Cucchetti, et al. · World Journal of Gastroenterology · 184
PDF
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
2018 · Serena De Matteis, Andrea Ragusa, et al. · Oxidative Medicine and Cellular Longevity · 160
PDF
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
2017 · Andrea Casadei Gardini, Luca Faloppi, et al. · European Journal of Cancer · 90
PDF
Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals
2018 · Andrea Costantini, Nadia Viola, et al. · Aging · 79
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus
2019 · Laura Del Coco, Daniele Vergara, et al. · Journal of Clinical Medicine · 69
PDF
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells
2012 · Giovanni Reddiconto, Claudia Toto, et al. · Blood · 54
PDF
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis
2022 · Giuseppe Bronte, Elisabetta Petracci, et al. · Frontiers in Immunology · 49
PDF
The Multifaceted Role of TGF-β in Gastrointestinal Tumors
2021 · Fabio Sabbadini, Monica Bertolini, et al. · Cancers · 45
PDF
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
2024 · Gianluca Storci, Francesco De Felice, et al. · Journal of Clinical Investigation · 32
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia
2015 · Gerardo Musuraca, Serena De Matteis, et al. · Journal of Translational Medicine · 31
PDF
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma
2018 · Matteo Canale, Paola Ulivi, et al. · Critical Reviews in Oncology/Hematology · 30
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin
2019 · Serena De Matteis, Emanuela Scarpi, et al. · International Journal of Molecular Sciences · 29
PDF
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
2018 · Serena De Matteis, Chiara Molinari, et al. · Journal of Translational Medicine · 29
PDF
Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer
2019 · Serena De Matteis, Matteo Canale, et al. · Journal of Oncology · 27
PDF
Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review
2022 · Umberto Pensato, Lorenzo Muccioli, et al. · Journal of Neurology · 25
PDF
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity
2023 · Serena De Matteis, Michele Dicataldo, et al. · Frontiers in Immunology · 17
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells
2020 · Roberta Napolitano, Serena De Matteis, et al. · Oncology Reports · 16
PDF
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma
2017 · Serena De Matteis, Anna Maria Granato, et al. · Digestive Diseases and Sciences · 16
Urinary Metabolic Biomarkers in Cancer Patients: An Overview
2021 · Serena De Matteis, Massimiliano Bonafè, et al. · Methods in molecular biology · 14
Blood–brain barrier breakdown, central nervous system cell damage, and infiltrated T cells as major adverse effects in CAR-T-related deaths: a literature review
2024 · Fabio Del Duca, Gabriele Napoletano, et al. · Frontiers in Medicine · 11
PDF
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis
2021 · Ilario Giovanni Rapposelli, Serena De Matteis, et al. · Cancers · 10
PDF
Comparative proteomic profiling of Hodgkin lymphoma cell lines
2015 · D Vergara, P Simeone, et al. · Molecular BioSystems · 10
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
2023 · Gabriella Chirumbolo, Michele Dicataldo, et al. · Transplantation and Cellular Therapy · 9
The emerging role of GSK‐3β in the pathobiology of classical Hodgkin lymphoma
2017 · Claudio Agostinelli, Silvia Carloni, et al. · Histopathology · 9
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
2022 · Enrico Maffini, Margherita Ursi, et al. · Frontiers in Oncology · 8
PDF
Works count: 72
Citation count: 1,109
H-index: 16
I10-index: 22
Year
Topic
Type